Filing Details
Bio Essence Corp (OTC:BIOE) filed a Form 8-K with the Securities and Exchange Commission on October 23, 2026, disclosing a material event.
8k filedOTC:BIOE
Bio Essence Corp (BIOE) Reports Material Event to SEC
Bio Essence Corp (OTC:BIOE) filed a Form 8-K with the Securities and Exchange Commission on October 23, 2026, disclosing a material event.
At publication ·
What changed
Bio Essence Corp (OTC:BIOE) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Bio Essence Corp filed a Form 8-K with the SEC on October 23, 2026, disclosing a material event requiring shareholder disclosure.
- The company's stock trades at $0.42 per share with a market capitalization of $2.0 million.
- Material events reported on Form 8-K can include leadership changes, agreements, acquisitions, asset sales, or financial guidance changes.
- The specific nature of Bio Essence Corp's disclosed event was not detailed in this announcement.
Market Context
Bio Essence Corp's stock currently trades at $0.42 with a market capitalization of $2.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Bio Essence Corp's stock.
All SEC filings for Bio Essence Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BIOE Stock Page
Frequently Asked Questions
Where can I read BIOE's SEC filings?
Browse all filings on our BIOE SEC filings page.
What types of SEC filings does Bio Essence Corp file?
Public companies like Bio Essence Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
